Late-stage, primary open-angle glaucoma in Europe: social and health care maintenance costs and quality of life of patients from 4 countries

References

• Weinreb RN, Khaw PT. Primary open-angle glaucoma. Lancet 2004; 363: 1711–20
   PubMed Web of Science ®Google Scholar
• Sommer A. Glaucoma risk factors observed in the Baltimore Eye Survey. Curr Opin Ophthalmol 1996; 7: 93–8
   PubMedGoogle Scholar
• Quigley HA, Broman AT. The number of people with glaucoma worldwide in 2010 and 2020. Br J Ophthalmol 2006; 90: 262–7
   PubMed Web of Science ®Google Scholar
• Lafuma A, Brezin A, Lopatriello S, . Evaluation of non-medical costs associated with visual impairment in four European countries: France, Italy, Germany and the United Kingdom. Pharmacoeconomics 2006; 24: 193–205
   PubMed Web of Science ®Google Scholar
• Buch H, Vinding T, La Cour M, . The prevalence and causes of bilateral and unilateral blindness in an elderly urban Danish population. The Copenhagen City Eye Study. Acta Ophthalmol Scand 2001; 79: 441–9
   PubMedGoogle Scholar
• Klaver CC, Wolfs RC, Vingerling JR, . Age-specific prevalence and causes of blindness and visual impairment in an older population: the Rotterdam Study. Arch Ophthalmol 1998; 116: 653–8
   PubMed Web of Science ®Google Scholar
• Traverso CE, Walt JG, Kelly SP, . Direct costs of glaucoma and severity of the disease: a multinational long term study of resource utilisation in Europe. Br J Ophthalmol 2005; 89: 1245–9
   PubMed Web of Science ®Google Scholar
• Lee PP, Walt JG, Doyle JJ, . A multicenter, retrospective pilot study of resource use and costs associated with severity of disease in glaucoma. Arch Ophthalmol 2006; 124: 12–9
   PubMed Web of Science ®Google Scholar
• Gieser DK, Tracy WR, O'Connell W, . Costs and utilization of end-stage glaucoma patients receiving visual rehabilitation care: a US multisite retrospective study. J Glaucoma 2006; 15: 419–25
   PubMed Web of Science ®Google Scholar
• Poulsen PB, Buchholz P, Walt JG, . Cost analysis of glaucoma-related blindness in Europe. International Congress Series 2005; 1282: 262–6
   Google Scholar
• Gupta V, Srinivasan G, Mei SS, . Utility values among glaucoma patients: an impact on the quality of life. Br J Ophthalmol 2005; 89: 1241–4
   PubMed Web of Science ®Google Scholar
• Kobelt G, Jonsson B, Bergstrom A, . Cost-effectiveness analysis in glaucoma: what drives utility? Results from a pilot study in Sweden. Acta Ophthalmol Scand 2006; 84: 363–71
   PubMedGoogle Scholar
• CRPM centre de Reeducation pour Malvoyants. Official prices from Assurance Maladie 2006.
   Google Scholar
• Curtis L, Netten A. Unit Costs of Health and Social Care. Canterbury: PSSRU at University of Kent; 2004
   Google Scholar
• Fees for service in primary sector. Danish Medical Association. 2005. Available at: www.laeger.dk. [Last accessed December 2006]
   Google Scholar
• Takstsystem 2006 – en vejledning. March 2006. Available at: http://www.sst.dk/publ/Publ2006/SESE/Takstsystem/Takstsystem2006.pdf [Last accessed 05 Feb 2008]
   Google Scholar
• NHS reference costs. Department of Health 2004. Available at: http://www.dh.gov.uk/PublicationsAndStatistics/PublicationsPolicyAndGuidance/PublicationsPolicyAndGuidanceArticle/fs/en?CONTENT_ID=4105545&chk=znAfqu. [Last accessed May 2006]
   Google Scholar
• Krauth C, Hessel F, Hansmeier T, . Empirical standard costs for health economic evaluation in Germany – a proposal by the working group methods in health economic evaluation. Gesundheitswesen 2005; 67: 736–46
   PubMed Web of Science ®Google Scholar
• L'Assurance Maladie. Available at: http://www.codage.ext.cnamts.fr. [Last accessed October 2005]
   Google Scholar
• Le Pen C, Ligier M, Berdeaux G. Cost-effectiveness and cost-utility analysis of travoprost versus latanoprost and timolol in the treatment of advanced glaucoma in five European countries: Austria, France, Germany, The Netherlands and the United Kingdom. J Med Econ 2005; 8: 67–84
   Google Scholar
• Service-public. Available at: www.service-public.fr. [Last accessed October 2005]
   Google Scholar
• Brooks R. EuroQol: the current state of play. Health Policy 1996; 37: 53–72
   PubMed Web of Science ®Google Scholar
• Coons SJ, Rao S, Keininger DL, . A comparative review of generic quality-of-life instruments. Pharmacoeconomics 2000; 17: 13–35
   PubMed Web of Science ®Google Scholar
• Drummond MF, O'Brien BJ, Stoddard GL, . Methods for the Economic Evaluation of Health Care Programmes, 2nd ed. Oxford: Oxford University Press 2007
   Google Scholar
• Dolan P, Gudex C, Kind P, . A social tariff for Euroqol: results from a United Kingdom general population survey. Centre for Health Economics, Discussion Paper 138. University of York; 1995
   Google Scholar
• Raina P, Wong M, Massfeller H. The relationship between sensory impairment and functional independence among elderly. BMC Geriatr 2004; 4: 3
   PubMedGoogle Scholar
• Statistics Denmark 2006. Available at: http://www.dst.dk/. [Last accessed January 2006]
   Google Scholar
• Montemayor F, Sibley LM, Courtright P, . Contribution of multiple glaucoma medications to visual function and quality of life in patients with glaucoma. Can J Ophthalmol 2001; 36: 385–90
   PubMed Web of Science ®Google Scholar
• Aspinall PA, Brice R, Vickers A, . Methodological issues arising from three studies which included conjoint analysis in visually impaired peoplePoster presented at: ISPOR 10th Annual European Congress, 20–23 October 2007; Dublin, Ireland
   Google Scholar